(Q51361440)

4 April 2018

title

Emergence of drug resistance in patients with tuberculosis cared for by the Indian health-care system: a dynamic modelling study. (English)

1 reference

4 April 2018

0 references

1 reference

5

Dick Menzies

1 reference

4 April 2018

author name string

Stephanie Law

1

1 reference

4 April 2018

Amy S Piatek

2

1 reference

4 April 2018

Cheri Vincent

3

1 reference

4 April 2018

Olivia Oxlade

4

1 reference

4 April 2018

publication date

19 December 2016

1 reference

4 April 2018

published in

Lancet Public Health

1 reference

4 April 2018

volume

2

1 reference

4 April 2018

issue

1

1 reference

4 April 2018

page(s)

e47-e55

1 reference

4 April 2018

Tuberculosis management by private practitioners in Mumbai, India: has anything changed in two decades?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2816%2930035-4

7 January 2021

Developing a tuberculosis transmission model that accounts for changes in population health

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2816%2930035-4

7 January 2021

Delays in diagnosis and treatment of pulmonary tuberculosis in India: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2816%2930035-4

7 January 2021

Estimation of content of anti-TB drugs supplied at centres of the Revised National TB Control Programme in Tamil Nadu, India

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2816%2930035-4

7 January 2021

Tuberculosis management practices by private practitioners in Andhra Pradesh, India

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2816%2930035-4

7 January 2021

Assessment of doctors' knowledge regarding tuberculosis management in Lucknow, India: a public-private sector comparison

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2816%2930035-4

7 January 2021

Use of standardised patients to assess antibiotic dispensing for tuberculosis by pharmacies in urban India: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2816%2930035-4

7 January 2021

Substandard and falsified anti-tuberculosis drugs: a preliminary field analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2816%2930035-4

7 January 2021

Default in the outpatient treatment of tuberculosis in two hospitals in Northern India

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2816%2930035-4

7 January 2021

Non-adherence of new pulmonary tuberculosis patients to anti-tuberculosis treatment

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2816%2930035-4

7 January 2021

An epidemiological study of newly diagnosed sputum positive tuberculosis patients in Dhubri district, Assam, India and the factors influencing their compliance to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2816%2930035-4

7 January 2021

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2816%2930035-4

7 January 2021

Do we need to detect isoniazid resistance in addition to rifampicin resistance in diagnostic tests for tuberculosis?

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2816%2930035-4

7 January 2021

Transmission of Multidrug-Resistant and Drug-Susceptible Tuberculosis within Households: A Prospective Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2816%2930035-4

7 January 2021

Clinical consequences and transmissibility of drug-resistant tuberculosis in southern Mexico

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2816%2930035-4

7 January 2021

Molecular epidemiology of tuberculosis in the Netherlands: a nationwide study from 1993 through 1997.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2816%2930035-4

7 January 2021

Effect of drug resistance on the generation of secondary cases of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2816%2930035-4

7 January 2021

Disease control implications of India's changing multi-drug resistant tuberculosis epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2816%2930035-4

7 January 2021

The Potential Impact of Up-Front Drug Sensitivity Testing on India's Epidemic of Multi-Drug Resistant Tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2816%2930035-4

7 January 2021

Transmission modeling and health systems: the case of TB in India

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2816%2930035-4

7 January 2021

Patient and Provider Reported Reasons for Lost to Follow Up in MDRTB Treatment: A Qualitative Study from a Drug Resistant TB Centre in India

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2816%2930035-4

7 January 2021

Adherence to tuberculosis treatment: lessons from the urban setting of Delhi, India

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2816%2930035-4

7 January 2021

In search of factors responsible for noncompliance among tuberculosis patients in Wardha District, India

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2816%2930035-4

7 January 2021

Public-private mix for tuberculosis care and control: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2816%2930035-4

7 January 2021

Accelerating TB notification from the private health sector in Delhi, India.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2816%2930035-4

7 January 2021

Reminder systems to improve patient adherence to tuberculosis clinic appointments for diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS2468-2667%2816%2930035-4

7 January 2021

10.1016/S2468-2667(16)30035-4

Identifiers

DOI

1 reference

4 April 2018

1 reference

4 April 2018